Related Experiment Video
Updated: Sep 1, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
miR-141 exacerbates lung ischemia-reperfusion injury by targeting EGFR/β-catenin axis-mediated autophagy
Miao Yang1,2, Xiaomei Ling1, Jinfang Xiao1
1Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China.
Abstract:
Some microRNAs (miRNAs) play important roles in lung ischemia-reperfusion injury (LIRI) injury. Here, this study aimed to examine whether miR-141 was related to lung ischemia-reperfusion injury (IRI) via regulating autophagy and the epidermal growth factor receptor (EGFR), and to explore the underlying signal transduction pathways. To this end, we constructed the LIRI cell model and mouse models, separately. According to RT-qPCR and Western blotting (WB) analysis results, miR-141 up-regulation together with β-catenin and EGFR down-regulation within mouse pulmonary microvascular endothelial cells (PMVECs) or lung tissues was related to lung IRI. Besides, we conducted dual-luciferase reporter assay, which suggested the binding of EGFR to miR-141. In addition, we carried out TUNEL staining, HE staining, and flow cytometric analysis to assess the apoptosis of PMVECs and the injury to mouse lung tissues. Furthermore, we performed light-chain immunofluorescence assay to examine autophagosomes within PMVECs. According to our results, miR-141 suppressed β-catenin level through reducing EGFR level. Besides, the miR-141/EGFR/β-catenin axis enhanced autophagy to aggravate LIRI. To sum up, miR-141 suppresses EGFR expression to inhibit β-catenin level, which subsequently aggravates autophagy and complicates LIRI. The above results offer the candidate therapeutic target for the treatment of lung IRI.
Insights
MicroRNA-141 (miR-141) exacerbates lung ischemia-reperfusion injury (LIRI) by suppressing epidermal growth factor receptor (EGFR) and increasing autophagy. This finding reveals miR-141 as a potential therapeutic target for LIRI treatment.
Area of Science:
- Biomedical research
- Molecular biology
- Cellular biology
Background:
- MicroRNAs (miRNAs) are implicated in lung ischemia-reperfusion injury (LIRI).
- The specific role of miR-141 in LIRI, particularly its regulation of autophagy and epidermal growth factor receptor (EGFR), remains unclear.
Purpose of the Study:
- To investigate the role of miR-141 in LIRI.
- To determine if miR-141 regulates autophagy and EGFR in LIRI.
- To elucidate the underlying signaling pathways involved.
Main Methods:
- Construction of LIRI cell and mouse models.
- RT-qPCR and Western blotting to analyze miR-141, EGFR, and β-catenin levels.
- Dual-luciferase reporter assay to confirm EGFR-miR-141 binding.
- TUNEL staining, HE staining, and flow cytometry for apoptosis and tissue injury assessment.
- Immunofluorescence assay to detect autophagosomes.
Main Results:
- miR-141 was upregulated, while EGFR and β-catenin were downregulated in lung IRI models.
- miR-141 directly binds to EGFR.
- miR-141 suppressed β-catenin levels by reducing EGFR.
- The miR-141/EGFR/β-catenin pathway promoted autophagy, worsening LIRI.
- miR-141 promotes LIRI by enhancing autophagy via the EGFR/β-catenin axis.
Conclusions:
- miR-141 aggravates lung ischemia-reperfusion injury by suppressing EGFR, reducing β-catenin, and enhancing autophagy.
- The miR-141/EGFR/β-catenin pathway is a key mechanism in LIRI.
- miR-141 represents a potential therapeutic target for treating lung IRI.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway

